Does HRT Increase Breast Cancer Risk? What the Latest Evidence Says
Introduction: If you have been thinking about HRT but feel nervous because of breast cancer headlines, you are not alone. HRT and breast cancer risk is one of the most searched, most misunderstood, and most emotionally loaded menopause topics. Many women are left wondering: Am I putting myself in danger, or am I avoiding treatment that could genuinely help me feel well again? The clearest answer is this: HRT and breast cancer risk depend on the type of HRT, how long it is used, your personal breast cancer risk, and whether you have a uterus or a history of breast cancer. NICE says oestrogen-only HRT has little or no increase in breast cancer risk, while combined HRT can increase risk, especially with longer use. (NICE) In this article, we will walk through what the evidence actually means, what is worth paying attention to, and how to have a calm, informed conversation with your clinician. What Is Hormone Replacement Therapy? HRT, or hormone replacement therapy, is treatment used to replace or support falling hormone levels during perimenopause and menopause. It is most often used to help symptoms such as hot flushes, night sweats, poor sleep, vaginal dryness, low mood, joint aches, brain fog, and reduced quality of life. There are different types: Oestrogen-only HRT: usually for women who have had a hysterectomy. Combined HRT: oestrogen plus a progestogen, used when the uterus is still present to protect the womb lining. Vaginal oestrogen: low-dose local treatment for vaginal dryness, bladder symptoms, painful sex, and recurrent urinary symptoms. Systemic HRT: tablets, patches, gels, sprays, or implants that affect the whole body. When people talk about HRT and breast cancer risk, they are usually talking about systemic HRT, especially combined oestrogen-progestogen therapy. Low-dose vaginal oestrogen is generally treated differently because very little is absorbed into the bloodstream, and major guidance does not link it with the same breast cancer risk pattern as systemic therapy. (The Lancet) FemPhases Menopause Symptom Checker Why Does It Happen? Breast tissue is hormone-sensitive. Oestrogen and progesterone can influence the growth of some breast cells. This does not mean HRT “automatically causes cancer,” but it helps explain why certain hormone combinations may slightly increase the chance of breast cancer being diagnosed in some women. i. The type of HRT matters The latest guidance consistently separates oestrogen-only HRT from combined HRT. NICE states there is “very little or no increase” in breast cancer risk with oestrogen-only HRT, while combined HRT is associated with an increased risk. (NICE) Combined HRT is often necessary for women with a uterus because taking oestrogen without enough progestogen can increase the risk of endometrial cancer. So this is not about one hormone being “good” and another being “bad.” It is about matching the safest treatment to your body. ii. Duration matters The longer systemic HRT is used, the more important individual risk review becomes. The large 2019 Lancet individual participant meta-analysis found that breast cancer risk increased with duration of menopausal hormone therapy use, except for vaginal oestrogens. (The Lancet) That does not mean every woman must stop HRT after a set number of years. It means the decision should be reviewed regularly, especially if symptoms or risk factors have changed, or the original reason for starting HRT has changed. iii. Your baseline risk matters A small relative increase can mean different things for different women. A woman with a strong family history, previous high-risk breast biopsy, dense breasts, obesity, high alcohol intake, or previous breast cancer may need more specialist guidance than someone with low baseline risk. The British Menopause Society highlights that HRT risk should be discussed alongside other breast cancer risk factors, including alcohol and obesity, rather than in isolation. (British Menopause Society) Signs and Symptoms HRT and breast cancer risk is not usually something you can “feel.” Breast cancer risk is about probability, not a pattern of symptoms. Still, breast awareness matters whether you use HRT or not. Common menopause symptoms that may lead women to consider HRT include: Hot flushes Night sweats Waking at 3–4 a.m. Mood changes or anxiety Brain fog Vaginal dryness or soreness Painful sex Recurrent urinary symptoms Joint aches Palpitations Low libido Fatigue Skin and hair changes Breast changes that should be checked include: A new breast lump or thickening Nipple discharge, especially if bloody New nipple inversion Dimpling or puckering of breast skin A rash or crusting around the nipple Persistent breast pain in one area Swelling, redness, or warmth A lump in the armpit Any change that feels unusual for you What Is Normal and When to Pay Attention? Some breast tenderness can happen when starting or adjusting HRT, especially if the dose or progestogen pattern changes. But new, persistent, one-sided, or unusual breast changes should always be assessed. a. Common Changes These may be common but are still worth monitoring: Mild breast tenderness after starting HRT Temporary bloating or fluid retention Light bleeding in the first few months of some HRT regimens Changes in sleep, mood, or energy while adjusting treatment Vaginal discharge with local oestrogen Cyclical breast discomfort with sequential combined HRT b. Needs Urgent Attention Do not ignore: A new breast lump Nipple bleeding or new discharge Bleeding after sex Heavy or persistent abnormal bleeding Severe pelvic pain Chest pain, shortness of breath, fainting, or sudden weakness Symptoms of anaemia, such as breathlessness, dizziness, or extreme fatigue Unexplained weight loss Severe mood changes or thoughts of self-harm Evidence-Based Solutions The safest approach to HRT and breast cancer risk is not panic or avoidance. It is personalised decision-making. A good menopause consultation should consider: Your age Menopause stage Whether you have a uterus Personal or family history of breast cancer Previous breast biopsies or genetic risk Your symptoms and how much they affect daily life Blood clot, stroke, heart disease, and migraine history Bone health Current medicines Your values and preferences For many healthy women under 60, or within 10 years of menopause, HRT can be an appropriate and effective treatment for
Does HRT Increase Breast Cancer Risk? What the Latest Evidence Says Read More »






